Anil B. Gaikwad - Publications

The AKI-CKD Continuum: Mechanisms and Therapeutic Interventions.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Published: August 08, 2026

Histone H4K5 deacetylation by enhanced HDAC1 expression drives endothelial inflammation in diabetes through repression of the KLF2-eNOS axis.

Journal: Human cell

Published: November 22, 2025

Emerging in Diabetic Cardiomyopathy: Molecular Pathways and Targets for Therapeutic Intervention.

Journal: Drug development research

Published: July 23, 2025

Corrigendum to "Design and development of chromene-3-carboxylate derivatives as antidiabetic agents: Exploring the antidiabetic potential via dual inhibition of angiotensin II type 1 receptor and neprilysin enzyme" [Europ. J. Med. Chem. 293 (2025) 117705].

Journal: European journal of medicinal chemistry

Published: June 17, 2025

A Novel Combination of Exogenous Klotho Combined With Telmisartan Ameliorated Diabetic Cardiomyopathy via an Antifibrotic Mechanism.

Journal: Cell biology international

Published: June 07, 2025

Novel molecular biomarkers in kidney diseases: bridging the gap between early detection and clinical implementation.

Journal: The Journal of pharmacy and pharmacology

Published: May 07, 2025

Flavokawain A Attenuated Chronic Kidney Disease: Evidence From Network Pharmacology and Experimental Verification.

Journal: Cell biology international

Published: March 04, 2025

Design and development of chromene-3-carboxylate derivatives as antidiabetic agents: Exploring the antidiabetic potential via dual inhibition of angiotensin II type 1 receptor and neprilysin enzyme.

Journal: European journal of medicinal chemistry

Published: January 20, 2025

Hinokitiol Prevents Diabetic Acute Kidney Injury by Mitigating ER Stress.

Journal: Cell biology international

Published: November 19, 2024

ULK1 as a therapeutic target in kidney diseases: Current perspective.

Journal: Expert opinion on therapeutic targets

Published: November 11, 2024

Management of inflammaging in kidney diseases: focusing on the current investigational drugs.

Journal: Expert opinion on investigational drugs

Published: October 15, 2024

Repurposing the familiar: Future treatment options against chronic kidney disease.

Journal: The Journal of pharmacy and pharmacology

Published: September 14, 2024